Astrazeneca

FromAstraZeneca ([email protected])
Subject (97)Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Preheader (97)Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Typography
Arial
Colors
Text Analysis
Body Words153
Subject Words16
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeOvernight

Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors

Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors